Adverse drug reactions in pediatrics with a study of in-hospital intensive surveillance

V R Dharnidharka1, P N Kandoth, R K Anand

  • 1Department of Pediatrics, T.N. Medical College, Bombay.

Indian Pediatrics
|June 1, 1993
PubMed

Insights

Adverse drug reactions (ADRs) in Indian children occurred at a lower frequency than in Western studies. While intensive surveillance increased ADR detection, it proved too resource-intensive for routine use.

Area of Science:

  • Pediatric Pharmacology
  • Drug Safety Surveillance
  • Clinical Toxicology

Background:

  • Adverse drug reactions (ADRs) pose a significant risk in pediatric populations.
  • Understanding ADR patterns in Indian children is crucial for public health.
  • Existing surveillance methods may not be optimal for resource-limited settings.

Purpose of the Study:

  • To prospectively investigate the incidence and characteristics of ADRs in Indian children.
  • To compare ADR rates in Indian children with Western data.
  • To evaluate the feasibility of an intensive surveillance scheme for ADR detection.

Main Methods:

  • A two-part prospective study was conducted at a teaching hospital.
  • Part 1: Intensive in-hospital surveillance (IISS) in one pediatric unit vs. a control unit over 6 months.
  • Part 2: Retrospective analysis of 40 ADR cases over 2 years.

Main Results:

  • ADR incidence was 1.73% with a 0.29% mortality rate in the monitored group.
  • ADR frequency and mortality were significantly lower than in a comparable Western study (p < 0.001).
  • Antimicrobials (especially sulfonamides) were common culprits, often causing skin rashes; anti-tuberculous and anti-convulsant drugs led to late-onset reactions.

Conclusions:

  • ADRs and associated mortality in Indian children appear lower than in Western populations.
  • Intensive surveillance (IISS) effectively increased ADR reporting but was too cumbersome for routine implementation.
  • Antimicrobials are a major cause of ADRs in this population, necessitating careful monitoring.

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...